These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9218156)

  • 1. The place of myeloid growth factors in the treatment of hairy-cell leukaemia.
    Christopoulos C; Fortis A; Nikzas D; Anevlavis E
    Clin Lab Haematol; 1997 Jun; 19(2):149-50. PubMed ID: 9218156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia.
    Lorber C; Willfort A; Ohler L; Jäger U; Schwarzinger I; Lechner K; Geissler K
    Ann Hematol; 1993 Jul; 67(1):13-6. PubMed ID: 7687471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of interferon-alpha and granulocyte colony-stimulating factor in hairy cell leukaemia with aplastic marrow.
    Osterholz J; Wohlleber M; Kahnt C; Schumacher K
    Eur J Haematol; 1995 Aug; 55(2):140-2. PubMed ID: 7543058
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.
    Glaspy JA; Baldwin GC; Robertson PA; Souza L; Vincent M; Ambersley J; Golde DW
    Ann Intern Med; 1988 Nov; 109(10):789-95. PubMed ID: 2461131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of granulocyte colony-stimulating factor to correct neutropenia in chronic lymphocytic leukaemia.
    Vickers M
    Clin Lab Haematol; 1997 Mar; 19(1):77-8. PubMed ID: 9146953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
    Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
    Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of 2-chlorodeoxyadenosine, granulocyte-colony-stimulating factor, and erythropoietin in a Jehovah's Witness with hairy cell leukemia.
    Couban S; Wilson WE
    Am J Hematol; 1995 Jul; 49(3):255-6. PubMed ID: 7541605
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats.
    Nohynek GJ; Plard JP; Wells MY; Zerial A; Roquet F
    Cancer Chemother Pharmacol; 1997; 39(3):259-66. PubMed ID: 8996530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Gisselbrecht C; Haioun C; Lepage E; Bastion Y; Tilly H; Bosly A; Dupriez B; Marit G; Herbrecht R; Deconinck E; Marolleau JP; Yver A; Dabouz-Harrouche F; Coiffier B; Reyes F
    Leuk Lymphoma; 1997 Apr; 25(3-4):289-300. PubMed ID: 9168439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation.
    Mac Manus MP; Clarke J; McCormick D; Abram WP
    Int J Radiat Oncol Biol Phys; 1993 Aug; 26(5):845-50. PubMed ID: 7688362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemia.
    Takeshita A; Saito H; Toyama K; Horiuchi A; Kuriya S; Furusawa S; Tsuruoka N; Takiguchi T; Matsuda T; Utsumi M; Shiku H; Matsui T; Egami K; Tamura K; Ohno R
    Int J Hematol; 2000 Feb; 71(2):136-43. PubMed ID: 10745623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed response to granulocyte colony-stimulating factor (G-CSF) in a case of severe neutropenia associated with large granular lymphocyte (LGL) leukemia.
    Genvresse I; Späth-Schwalbe E; Lukowsky A; Possinger K
    Eur J Haematol; 1998 Feb; 60(2):133-4. PubMed ID: 9508355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hair cell leukemia with 2-chlorodeoxyadenosine and G-CSF].
    Bengió R; Pérez M; Sarmiento M; Raña P; Sánchez Lucero A; Sarto A; Arrossagaray G
    Medicina (B Aires); 1996; 56(5 Pt 1):534. PubMed ID: 9239892
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor.
    Furukawa T; Takahashi M; Moriyama Y; Koike T; Kurokawa I; Shibata A
    Ann Hematol; 1991 Feb; 62(1):22-4. PubMed ID: 1709572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myeloic leukemia: evaluation of colony-stimulating factors].
    Hiddemann W
    Dtsch Med Wochenschr; 2012 Nov; 137(45):2306. PubMed ID: 23111791
    [No Abstract]   [Full Text] [Related]  

  • 16. Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation.
    Gisselbrecht C; Prentice HG; Bacigalupo A; Biron P; Milpied N; Rubie H; Cunningham D; Legros M; Pico JL; Linch DC
    Lancet; 1994 Mar; 343(8899):696-700. PubMed ID: 7510813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.
    Bradstock K; Matthews J; Young G; Lowenthal R; Baxter H; Arthur C; Bashford J; Brighton T; Cannell P; Dunlop L; Durrant S; Enno A; Eliadis P; Gill D; Gillett A; Gottlieb D; Januszewicz H; Joshua D; Leahy M; Schwarer A; Taylor K;
    Leukemia; 2001 Sep; 15(9):1331-8. PubMed ID: 11516093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M; Urakami T; Watanabe S; Shimizu H; Inana I; Kikkawa Y; Kitagawa T
    Acta Paediatr Jpn; 1993 Apr; 35(2):124-6. PubMed ID: 7684881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor for neutropenia secondary to ticlopidine.
    Ruiz-Irastorza G; Alonso JJ; Iglesias JJ; Aguirre C
    Acta Haematol; 1994; 91(2):106-7. PubMed ID: 7517606
    [No Abstract]   [Full Text] [Related]  

  • 20. Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.
    Frampton JE; Yarker YE; Goa KL
    Drugs; 1995 May; 49(5):767-93. PubMed ID: 7541335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.